Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Zero Based Budgeting assigns every dollar a purpose, directly linking spending to savings goals and building a stronger financial cushion.
18,862 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Quantum names showed a broad pullback after a sharp rally, with IonQ down about 7% and D-Wave slipping near 8% as inv...
Microsoft sits at a pivotal price near $420 as quarterly results underscore AI momentum and capex intensity. This rep...
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
The AI hype has captivated many investors, but the long game can be found in the industrial sector. This guide highli...
SpaceX is signaling a public debut that could rewrite IPO benchmarks, even as critics warn the proposed governance st...
A six-page FDA memo quietly opens the door for certain nicotine products to reach the market before complete regulato...
As AI accelerates, the stock narrative centers on NVIDIA, AMD, and Broadcom. This guide breaks down why each could de...
A CEO’s drastic HR purge and a high-profile EEOC lawsuit against The New York Times collide at a moment of market vol...
Energy stocks are rallying as market volatility persists, highlighting the best stocks right now for investors seekin...
Cerebras hit the market with fireworks, then cooled off quickly. This guide explains what happened, how to value the ...
As AI expands from novelty to durable demand, investors wonder if the AI trade is entering its second wave. This arti...